Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression.
about
Adaptive responses of androgen receptor signaling in castration-resistant prostate cancerUncovering the roles of miRNAs and their relationship with androgen receptor in prostate cancerA dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cellsMicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samplesKnowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer typesmiR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesisMicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2RNAi-mediated knockdown of E2F2 inhibits tumorigenicity of human glioblastoma cells.MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.Role of non-coding sequence variants in cancer.Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31.Tumor suppression by miR-31 in esophageal carcinoma is p21-dependent.MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma.SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cellsMicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescenceExpression of dicer and its related miRNAs in the progression of prostate cancerMicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer.Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression.miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation.Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastomaLARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotationsmiR-31 and miR-17-5p levels change during transformation of follicular lymphomaThe relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathwayMicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discoveryMicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma.MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5.Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2.Epigenetic regulation of miR-21 in colorectal cancer: ITGB4 as a novel miR-21 target and a three-gene network (miR-21-ITGΒ4-PDCD4) as predictor of metastatic tumor potential.Differential microRNA expression is associated with androgen receptor expression in breast cancerThe role of miR-24 as a race related genetic factor in prostate cancer.Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer.Roles of microRNAs during prostatic tumorigenesis and tumor progression.The diverse role of miR-31 in regulating cancer associated phenotypes.Androgen receptor signaling in prostate cancer.MicroRNAs and drug resistance in prostate cancers.Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects
P2860
Q26795625-801D765D-15A4-447B-AF92-F5938053E4B2Q27014171-1E54C425-0AE5-4780-8108-F2F1EDA58004Q28573536-4E048C33-C920-49CE-AA19-E8BB725955F5Q30859743-BA74612B-3409-4CE4-A276-85E661383C93Q33557718-C3AFA326-7816-43ED-AAD7-B5F35FDA39EDQ34023389-9B285DE6-D480-4746-9A86-45DDC358EDDFQ34104063-8397D68E-86F1-44E0-9494-2B335889B14FQ34141445-A41AC043-9531-4962-B4A4-2516108AB3C3Q34497810-1D35DD79-D2FB-4E69-9C6D-DAAEC71513A7Q34509633-B44CD9F0-C241-4BC9-8994-C2ED2B46E88DQ34541700-F080DBF8-3596-4125-9137-B81E95F69CEFQ34786656-96D4A918-0EBC-4FB6-BAAA-BE3A4DDAEEE8Q35027675-5A8619F3-C2D8-45A8-BCB8-61B4457FA94DQ35137803-9215E782-1AB2-40B9-AF7A-1EC13E64C8A6Q35218210-0E35AE20-9232-49AA-B8EB-BC530F5081D6Q35451400-AE9AA56B-CDF0-480A-B6D8-D39AF67F43F0Q35576785-C507FA4E-C3AB-4231-B84C-0167FB5EF2B3Q35781512-F0C0CB1D-9834-4CB9-8F24-92F4DDB32B07Q35814277-4C274669-C468-42D6-98F5-D0A8F0629608Q35886573-952D78E6-606C-4DCF-9C66-9656B6C699A0Q35897588-5DD961B6-59A4-4CC5-A00F-74907CD8340BQ36002695-4E00218D-BAB1-4321-B052-3EEC2EA7FDB4Q36147506-CA1081BC-3763-4045-8362-B1F10E432B50Q36232178-79B5FBB8-1999-485E-B6E7-86520E23D5E3Q36676636-9F3E34EE-53BB-4A4C-836F-3ED766AEA13CQ36719087-52FCE073-8190-4D2C-B981-8462BA782A5CQ37022273-07C212B0-D315-494B-A855-815DA29BF2C5Q37113174-42E3577A-443D-4A01-B775-464F95356424Q37295098-8F26BCB3-B991-4E1A-BF9D-772E61A99BA2Q37317285-0BDBF149-559C-48FD-8F38-BD85C7456874Q37392777-9BEC6CEC-A3D6-438D-9448-6720D743DB66Q37591522-9C3026AF-C8F2-447E-AEE4-AA685CB2E90BQ37707636-D89F4CB4-C967-4C7D-8BD1-039BD3643342Q37725482-147C543F-DAD4-46A3-8DEE-E01A9750C57AQ37737611-BC2540C7-5D24-44A2-AC72-D2C1EBBDBC73Q38086009-3598CE6F-502A-4C03-B12B-EDA9C83F8FC5Q38133768-75E05F74-C076-4B18-9D2F-21BE9708BD62Q38175320-525E83C7-F690-4A85-992A-EA2BE6879F97Q38205266-4176F3F2-647C-4B21-B943-53FB1410A657Q38212470-0E38D7A8-EFCF-4626-ABBA-93C0960B6792
P2860
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Epigenetic repression of miR-3 ...... o prostate cancer progression.
@en
Epigenetic repression of miR-3 ...... o prostate cancer progression.
@nl
type
label
Epigenetic repression of miR-3 ...... o prostate cancer progression.
@en
Epigenetic repression of miR-3 ...... o prostate cancer progression.
@nl
prefLabel
Epigenetic repression of miR-3 ...... o prostate cancer progression.
@en
Epigenetic repression of miR-3 ...... o prostate cancer progression.
@nl
P2093
P2860
P50
P1433
P1476
Epigenetic repression of miR-3 ...... o prostate cancer progression.
@en
P2093
Ari M Melnick
Ashutosh K Tewari
Eugenia Giannopoulou
Himisha Beltran
Juan Miguel Mosquera
Kyung Park
Olivier Elemento
Pedro Alves
Pei-Chun Lin
Samprit Banerjee
P2860
P304
P356
10.1158/0008-5472.CAN-12-2968
P407
P577
2012-12-11T00:00:00Z